Omar Usmani (London, United Kingdom), Reinoud Gosens (Groningen, Netherlands), Maria Luisa Bocchino (Naples, Italy), Tania Maes (Gent, Belgium)
Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation
Michael Wortley (London, United Kingdom), Michael Wortley, John Adcock, Eric Dubuis, Sarah Maher, Sara Bonvini, Mark Birrell, Maria Belvisi
|  |
Pharmacological profile of a novel, potent and oral TRPA1 antagonist. Characterization in a preclinical model of induced cough
Monica Aparici Virgili (Sant Feliu de Llobregat, Spain), Gema Tarrasón, Irene Jover, Carla Carcasona, Joan Antoni Fernández-Blanco, Peter Eichhorn, Amadeu Gavaldà, Jorge De Alba, Richard Roberts, Montserrat Miralpeix, Mònica Aparici
| |
Reliability and validity of a Turkish version of Leicester cough questionnaire
Yavuz Havlucu (Manisa, Turkey), Nazmiye Akis Gonen, Yavuz Havlucu, Arzu Yorgancioglu, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik
| |
Prediction of human lung PK for AZD7624, an inhaled P38 inhibitor for the treatment of COPD
Sara Asimus (Mölndal, Sweden), Mats Någård, Rikard Pehrson, Sara Asimus, Tove Hegelund, Paul Jansson, Naimish Patel
| |
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Giuseppe Spaziano (Naples, Italy), Giuseppe Spaziano, Maria Matteis, Rosalinda Sorrentino, Fiorentina Roviezzo, Giuseppe Cirino, Aldo Pinto, Francesco Rossi, Gioia Tartaglione, Manuela Sgambato, Bruno D’Agostino
|  |
BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model
Ariana Corrêa Florencio (São Paulo, Brazil), Ariana Florencio, Fernanda Magalhães Arantes-Costa, Robson Santos de Almeida, Thayse Regina Brüggemann, Sérgio D. Sasaki, Milton A. Martins, Iolanda F.L.C. Tibério, Fernanda D.T.Q.S. Lopes, Edna A. Leick
| |
Atorvastatin lowers inflammatory sputum mediators in smokers with asthma
Catherine Charron (London, United Kingdom), Catherine Charron, Rekha Chaudhuri, Mark Spears, Kazuhiro Ito, Charles McSharry, Neil Thomson
| |
Decoy chemokine neutraligands with anti-asthmatic activity
Dayana Abboud (Illkirch, France), Dayana Abboud, François Daubeuf, Quoc tuan Do, Valérie Utard, Pascal Villa, Jacques Haiech, Dominique Bonnet, Marcel Hibert, Philippe Bernard, Jean-Luc Galzi, Nelly Frossard
| |
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Francesco Bini (Pavia, Italy), Francesco Bini, Roberto Ruggiero, Noemi Grassi, Giorgio De Benernardi, Adriano Vaghi
| |
Evaluation of methotrexate in the treatment of severe asthma
Anita Molard (Strasbourg, France), François Hervy, Gairard-Dory Anne-Cécile, Anita Molard, Carine Metz-Favre, Cindy Barnig, Bénédicte Gourieux, Frédéric De Blay
| |
Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps
Anselm Morell (Valencia, Spain), Anselm Morell, Javier Milara, Lucia Díaz, Beatriz Ballester, Teresa Peiró, Sonia Gonzalez, Pilar Bañuls, Julio Cortijo
| |
Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies
Tatiana Molostova (Moscow, Russian Federation), Tatiana Molostova, Alexander Chuchalin, Sofia Skachilova, Elena Shilova, Yuriy Kalinin, Tamerlan Balaev, Irina Badygina, Alexander Solovyev
| |
Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile
Gaki Nima (Delhi, India), Gaki Nima, Balakrishnan Menon, Santosh Jha
| |
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
Domenico Spina (London, United Kingdom), Radhakrishnan Venkatasamy, Clive Page, Domenico Spina
| |
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Michela Maria Bellocchia (Turin, Italy), Michela Bellocchia, Monica Boita, Filippo Patrucco, Cinzia Ferrero, Giulia Verri, Daniela Libertucci, Francesco Coni, Giuseppe Tabbia, Alessio Mattei, Caterina Bucca
| |
The efficacy of lung volume reduction coil practice to type-2 respiratory insufficiency in severe COPD cases
Fidan Sever (Izmir , Turkey), Fidan Sever, Askin Gulsen, Ayse Pelin Girgin, Necdet Batuhan Tamci, Hatice Yilmaz
| |
Additive effect of targeted lung denervation plus drug in patients with COPD
Coenraad Frederik Nicolaas Koegelenberg (Cape Town, South Africa), Coenraad Koegelenberg, Johan Theron, Dirk-Jan Slebos, Karin Klooster, Martin Mayse, Chris T. Bolliger
| |
Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea
Helen Fowles (Hull, United Kingdom), Helen Fowles, Alyn Morice, Yvette Hayman, Kayleigh Arnell
| |
Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo
Martin Lehner (Neumarkt, Germany), Jan Seibel, Martin D. Lehner, Jutta Haunschild
| |